Advances in Longevity and Aging Research with Dr. Eric Verdin, MD


In this interview, Seneque and Dr. Verdin discuss the importance of NAD+, longevity, aging and benefits of supplementing with the NAD precursor NMN-C


Eric Verdin, MD is the president and chief executive officer of the Buck Institute for Research on Aging. Dr. Verdin’s laboratory focuses on the role of epigenetic regulators in the aging process. Dr. Verdin studies how metabolism, diet, and small molecules regulate the activity of HDACs and sirtuins, and thereby the aging process itself and its associated diseases, including Alzheimer’s. He has published more than 210 scientific papers and holds more than 15 patents. He is a highly cited scientist and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation.